Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirs

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 5, 2015, Pages 2944-2948

  Thompson, Corbin G ^a   Bokhart, Mark T ^b   Sykes, Craig ^a   Adamson, Lourdes ^c   Fedoriw, Yuri ^d   Luciw, Paul A ^c   Muddiman, David C ^b   Kashuba, Angela D M ^a   Rosen, Elias P ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; ANTIRETROVIRUS AGENT; BENZOXAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TISSUE LEVEL; GRAY MATTER; HUMAN IMMUNODEFICIENCY VIRUS; INFRARED SPECTROSCOPY; LAMINA PROPRIA; LYMPH FOLLICLE; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; STEADY STATE; TISSUE DISTRIBUTION; ANIMAL; LYMPH NODE; MACACA; METABOLISM; PROCEDURES;

ANIMALS; ANTI-RETROVIRAL AGENTS; BENZOXAZINES; GRAY MATTER; LYMPH NODES; MACACA; MASS SPECTROMETRY;

EID: 84931274825     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04952-14     Document Type: Article

References (25)

1. Palmer S, Josefsson L, Coffin JM. 2011. HIV reservoirs and the possibility of a cure for HIV infection. J Intern Med 270:550-560. doi:http://dx.doi.org/10.1111/j.1365-2796.2011.02457.x.
2. Chun T-W, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahn CW, Kottilil S, Moir S, Mican JM, Mullins JI, Ward DJ, Kovacs JA, Mannon PJ, Fauci AS. 2008. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 197:714-720. http://dx.doi.org/10.1086/527324.
3. Fletcher CV, Staskus K, Wietgrefe SW, Rothenberger M, Reilly C, Chipman JF, Beilman GJ, Khoruts A, Thorkelson A, Schmidt TE, Anderson J, Perkey K, Stevenson M, Perelson AS, Douek DC, Haase AT, Schacker TW. 2014. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 111:2307-2312. http://dx.doi.org/10.1073/pnas.1318249111.
4. Dumond JB, Yeh RF, Patterson KB, Corbett AH, Jung BH, Rezk NL, Bridges AS, Steward PW, Cohen MS, Kashuba AD. 2007. Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS 21:1899-1907. http://dx.doi.org/10.1097/QAD.0b013e328270385a.
5. Podany AT, Winchester LC, Robbins BL, Fletcher CV. 2014. Quantification of cell-associated atazanavir, darunavir, lopinavir, ritonavir, and efavirenz concentrations in human mononuclear cell extracts. Antimicrob Agents Chemother 58:2866-2870. http://dx.doi.org/10.1128/AAC.02551-13.
6. Thompson CG, Rosen E, Sykes C, Fedoriw Y, Luciw PA, Muddiman DC, Kashuba AD. 2014. Characterizing antiretroviral distribution within active viral reservoirs using mass spectrometry imaging, abstr p-09, p 36-37. Abstract Book 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, Washington, DC. http://regist2.virology-education.com/abstractbook/2014-4.pdf.
7. Prideaux B, Stoeckli M. 2012. Mass spectrometry imaging for drug distribution studies. J Proteomics 75:4999-5013. http://dx.doi.org/10.1016/j.jprot.2012.07.028.
8. Robichaud G, Barry JA, Garrard KP, Muddiman DC. 2013. Infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI) imaging source couple to a FT-ICR mass spectrometer. J Am Soc Mass Spectrom 24:92-100. http://dx.doi.org/10.1007/s13361-012-0505-9.
9. Barry JA, Robichaud G, Bokhart MT, Thompson CG, Sykes C, Kashuba AD, Muddiman DC. 2014. Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS/MS SRM assay. J Am Soc Mass Spectrom 25:2038-2047. http://dx.doi.org/10.1007/s13361-014-0884-1.
10. Bokhart MT, Rosen E, Thompson C, Sykes C, Kashuba AD, Muddiman DC. 16 October 2014. Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization. Anal Bioanal Chem http://dx.doi.org/10.1007/s00216-014-8220-y.
11. Gratton S, Cheynier R, Dumaurier M-J, Oksenhendler E, Wain-Hobson S. 2000. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc Natl Acad Sci U S A 97:14566-14571. http://dx.doi.org/10.1073/pnas.97.26.14566.
12. Burton GF, Keele BF, Estes JD, Thacker TC, Gartner S. 2002. Follicular dendritic cell contributions to HIV pathogenesis. Immunology 14:275-284. http://dx.doi.org/10.1016/S1044-5323(02)00060-X.
13. Avettand-Fenoel V, Hocqueloux L, Muller-Trutwin M, Prazuck T, Melard A, Chaix ML, Agoute E, Michau C, Rouzioux C. 2011. Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART. J Med Virol 83:1499-1507. http://dx.doi.org/10.1002/jmv.22132.
14. Zink MC, Clements JE. 2002. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J Neurovirol 8(Suppl 2):S42-S48. http://dx.doi.org/10.1080/13550280290101076.
15. Van Rompay KK. 2012. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies. AIDS Res Hum Retroviruses 28:16-35. http://dx.doi.org/10.1089/aid.2011.0234.
16. North TW, Van Rompay KK, Higgins J, Matthews TB, Wadford DA, Pedersen NC, Schinazi RF. 2005. Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. J Virol 79:7349-7354. http://dx.doi.org/10.1128/JVI.79.12.7349-7354.2005.
17. Hofman MJ, Higgins J, Matthews TB, Pedersen NC, Tan C, Schinazi RF, North TW. 2004. Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. Antimicrob Agents Chemother 48:3483-3490. http://dx.doi.org/10.1128/AAC.48.9.3483-3490.2004.
18. North TW, Higgins J, Deere JD, Hayes TL, Villalobos A, Adamson L, Schacklett BL, Schinazi RF, Luciw PA. 2010. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol 84:2913-2922. http://dx.doi.org/10.1128/JVI.02356-09.
19. Kessner D, Chambers M, Burke R, Agus D, Mallick P. 2008. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24:2534-2536. http://dx.doi.org/10.1093/bioinformatics/btn323.
20. Robichaud G, Garrard KP, Barry JA, Muddiman DC. 2013. MSiReader: an open-source interface to view and analyze high resolving power MS imaging files on Matlab platform. J Am Soc Mass Spectrom 24:718-721. http://dx.doi.org/10.1007/s13361-013-0607-z.
21. Liu X, Natta Van K, Yeo H, Vilenski O, Weller PE, Worboys PD, Monshouwer M. 2009. Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos 37:787-793. http://dx.doi.org/10.1124/dmd.108.024125.
22. de Lange E, Danhof M. 2002. Cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 41:691-703. http://dx.doi.org/10.2165/00003088-200241100-00001.
23. Thompson CG, Sedykh A, Nicol MR, Muratov E, Fourches D, Tropsha A, Kashuba AD. 2014. Cheminformatics analysis to identify predictors. AIDS Res Hum Retroviruses 30:1058-1064. http://dx.doi.org/10.1089/aid.2013.0254.
24. Peroni RN, Di Gennaro SS, Hocht C, Chiappetta DA, Rubio MC, Sosnik A, Bramuglia GF. 2011. Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat. Biochem Pharmacol 82:1227-1233. http://dx.doi.org/10.1016/j.bcp.2011.07.081.
25. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer J, Opravil M, Pantaleo G, Retelka D, Ruiz L, Schinkel AH, Vernazza P, Eap CB, Telenti A. 2002. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 359:30-36. http://dx.doi.org/10.1016/S0140-6736(02)07276-8.